SCHEMBL22762016

SCHEMBL22762016

CCOC(=O)CN1C=CC(O)NC1=O

nearest known ligand 0.45

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ GSK3A P49840 1/20 0.45
▸ GSK3B P49841 1/20 0.45
▸ ABL1 P00519 1/20 0.44
▸ RIN1 Q13671 1/20 0.44
▸ TDP1 Q9NUW8 1/20 0.44
▸ SMN1; SMN2 Q16637 1/20 0.42
▸ ALDH1A1 P00352 4/20 0.41
▸ PIN1 Q13526 1/20 0.41
▸ PIN4 Q9Y237 1/20 0.41
▸ ELANE P08246 1/20 0.40
▸ CYP2C19 P33261 1/20 0.39
▸ MAPK1 P28482 1/20 0.39
▸ MAPT P10636 2/20 0.38
▸ HTT P42858 2/20 0.38
▸ LMNA P02545 1/20 0.38
▸ KMT2A Q03164 1/20 0.38
▸ CA12 O43570 1/20 0.38
▸ CA9 Q16790 1/20 0.38
▸ KDM4E B2RXH2 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6348434 0.66 GSK3A (0.44) GSK3AGSK3BABL1RIN1TDP1
SCHEMBL15122509 0.64 TDP1 (0.44) GSK3AGSK3BABL1RIN1TDP1
SCHEMBL24282303 0.64 TDP1 (0.44) GSK3AGSK3BABL1RIN1TDP1
SCHEMBL15122510 0.64 TDP1 (0.44) GSK3AGSK3BABL1RIN1TDP1
SCHEMBL7456326 0.64 ABL1 (0.51) GSK3AGSK3BABL1RIN1TDP1
SCHEMBL22511412 0.63 LMNA (0.47) GSK3AGSK3BABL1RIN1TDP1
SCHEMBL9662940 0.63 GSK3A (0.47) GSK3AGSK3BALDH1A1PIN1PIN4
SCHEMBL3384734 0.63 GSK3A (1.00) GSK3AGSK3BALDH1A1PIN1PIN4
SCHEMBL3582727 0.61 GSK3A (0.50) GSK3AGSK3BALDH1A1PIN1PIN4
SCHEMBL23511651 0.61 ABL1 (0.45) GSK3AGSK3BABL1RIN1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020247782-A1 NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF AVIDITY BIOSCIENCES, INC. (US) 2020-12-10 — — WO disclosed
Send feedback